Ondansetron prevents chemotherapy-induced acute vomiting but is less effective for anticipatory vomiting. The pharmacological explanation is:

• A Ondansetron is poorly absorbed orally and does not reach central vomiting centers for anticipatory vomiting
• B Anticipatory vomiting is mediated by H1 receptors in the vestibular nuclei, not targeted by ondansetron
• C Ondansetron is a 5-HT3 antagonist acting on vagal afferents and area postrema; anticipatory vomiting is a conditioned response involving cortical/limbic pathways where 5-HT3 plays a minimal role ✓
• D Ondansetron blocks the chemoreceptor trigger zone (CTZ) but not the vomiting center itself

Explanation

Chemotherapy activates enterochromaffin cells in the GI mucosa to release serotonin (5-HT), which stimulates 5-HT3 receptors on vagal afferents and in the CTZ/area postrema — all blocked by ondansetron. Anticipatory vomiting is a classically conditioned psychological response mediated through higher cortical and limbic circuits (learned association with chemotherapy setting), where dopaminergic and GABA-ergic pathways predominate; 5-HT3 plays a minimal role in this conditioned reflex. Benzodiazepines (anxiolytics) are most effective for anticipatory vomiting.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.